Note: The 2012, 2013 publications have not been audited.
Jump to: Publications | Grants and Consultancies | HDR completions
2012 School of Medicine
Konstantopoulos, Nicky, Molero, Juan C., McGee, Sean L., Spolding, Briana, Connor, Tim, de Vries, Melissa, Wanyonyi, Stephen, Fahey, Richard, Morrison, Shona, Swinton, Coutney, Jones, Sharon, Cooper, Adrian, Garcia-Guerra, Lucia, Foletta, Victoria C., Krippner, Guy*, Andrikopoulos, Sofianos* and Walder, Ken R. (2012) Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo, Diabetes, vol. 61, no. 8, pp. 2146-2154, American Diabetes Association, Alexandria, Va. [C1]
ERA journal ID: 16015 – Scopus EID: 2-s2.0-84864378844
Citation counts:Scopus - 1,
Thomson - 1
DRO entry for this publication
2008 School of Medicine
Spolding, B., Connor, T., DeVries, M., Wanyonyi, S., Cooper, A., Lee, S., Molero, J. C. and Walder, K. (2008) VVP808 is a novel agent that improves glucose tolerance in DIO mice, in Unknown (ed.), ADS & ADEA 2008 : Proceedings of the 2008 ADS & ADEA annual scientific meeting, ADS & ADEA, Melbourne, Vic. [E1.1]
DRO entry for this publication
2006 School of Exercise and Nutrition Sciences
Foletta, Victoria, Segal, David, Sanigorski, Andrew, Broz, I., Spolding, Briana, Windmill, Kelly, Bozaoglu, Kiymet, Todd, S., Collier, Gregory and Walder, Ken (2006) Hepatic gene expression profiling in fed and fasted Psyammomys obesus, ICO 2006 : Progress in obesity research 10 : proceedings of the 10th International Congress on Obesity, International Association for the Study of Obesity, London, England [E3]
DRO entry for this publication
2005 School of Exercise and Nutrition Sciences
Spolding, Briana, Windmill, Kelly, Jowett, Jeremy*, Gluschenko, K.*, Segal, David, Walder, Ken, Comuzzie, A.*, Kissebah, A.*, Collier, Gregory and Blangero, John* (2005) Quantitative trait loci fine mapping by expression profiling., ADS & ADEA 2005 : Australian Diabetes Society and Australian Diabetes Educators Association, Annual Scientific Meeting, Australian Diabetes Society and Australian Diabetes Educators Association, Sydney, N.S.W. [E3]
DRO entry for this publication
All years
Research Income - Other Public Sector Funding
Walder, K, Connor, T and Spolding, B. Determination of RIPTAC bioavailability, pharmacokinetics and distribution [U]
- 2011: $12,000
Research Income - Industry and Other Funding
Walder, K, Konstantopoulos, N, Spolding, B and Lee, S. New studies to investigate efficacy and safety of VVP808 (Part A) [V]
- 2011: $90,000
No completions found or audited.
DRO to publications collection last synchronised: Thursday 20th June 2013 5:15pm